- Home
- TCRT vs ATCH Comparison
TCRT vs ATCH Comparison
Compare TCRT & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- ATCH
- Stock Information
- Founded
- TCRT 1998
- ATCH 2022
- Country
- TCRT United States
- ATCH United States
- Employees
- TCRT N/A
- ATCH N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- TCRT Health Care
- ATCH
- Exchange
- TCRT Nasdaq
- ATCH Nasdaq
- Market Cap
- TCRT 3.8M
- ATCH 3.7M
- IPO Year
- TCRT N/A
- ATCH N/A
- Fundamental
- Price
- TCRT $2.08
- ATCH $0.17
- Analyst Decision
- TCRT
- ATCH
- Analyst Count
- TCRT 0
- ATCH 0
- Target Price
- TCRT N/A
- ATCH N/A
- AVG Volume (30 Days)
- TCRT 14.2K
- ATCH 11.0M
- Earning Date
- TCRT 11-14-2024
- ATCH 11-29-2024
- Dividend Yield
- TCRT N/A
- ATCH N/A
- EPS Growth
- TCRT N/A
- ATCH N/A
- EPS
- TCRT N/A
- ATCH 0.04
- Revenue
- TCRT $7,000.00
- ATCH N/A
- Revenue This Year
- TCRT N/A
- ATCH N/A
- Revenue Next Year
- TCRT N/A
- ATCH N/A
- P/E Ratio
- TCRT N/A
- ATCH $4.04
- Revenue Growth
- TCRT N/A
- ATCH N/A
- 52 Week Low
- TCRT $1.95
- ATCH $0.12
- 52 Week High
- TCRT $33.00
- ATCH $10.26
- Technical
- Relative Strength Index (RSI)
- TCRT 44.32
- ATCH 44.35
- Support Level
- TCRT $2.00
- ATCH $0.17
- Resistance Level
- TCRT $2.86
- ATCH $0.26
- Average True Range (ATR)
- TCRT 0.17
- ATCH 0.04
- MACD
- TCRT 0.05
- ATCH 0.00
- Stochastic Oscillator
- TCRT 14.29
- ATCH 12.92
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.